Establishment of a stable CHO cell line with high level expression of recombinant porcine IFN-β

Cytokine

Volumn 54, Issue 3, 2011, Pages 324-329

  Chen, Weiye ^a,b   Cao, Wenyan ^a   Zhao, Huijun ^a   Hu, Qianqian ^a,b   Qu, Linmao ^a,b   Hu, Sen ^a   Ge, Jinying ^a   Wen, Zhiyuan ^a   Wang, Xijun ^a   Li, HaoBo ^a,b   Huang, Kehe ^b   Bu, Zhigao ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

^b NANJING AGRICULTURAL UNIVERSITY   (China)

Author keywords

Antiviral activity; Biological activity; CHO K1 cells; Porcine interferon ; Stable expression

Indexed keywords

BETA INTERFERON; LUCIFERASE; RECOMBINANT PROTEIN;

ANIMAL CELL; ARTICLE; CELL CLONE; CELL CULTURE; CELL PROTECTION; CELL SELECTION; CELL STRAIN; CHICKEN; CHO CELL; CONTROLLED STUDY; CYTOMEGALOVIRUS; FEMALE; GENE EXPRESSION; INFECTION RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; PSEUDORABIES HERPETOVIRUS; REPORTER GENE; SWINE; TRANSMISSIBLE GASTROENTERITIS VIRUS;

ANIMALS; ANTIBODIES; ANTIVIRAL AGENTS; CHICKENS; CHO CELLS; CRICETINAE; CRICETULUS; DOGS; INTERFERON-BETA; KIDNEY; PLASMIDS; PROMOTER REGIONS, GENETIC; RECOMBINANT PROTEINS; SWINE; TIME FACTORS;

MAMMALIA; RABIES VIRUS; SUS; TRANSMISSIBLE GASTROENTERITIS VIRUS;

EID: 79955131850     PISSN: 10434666     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cyto.2010.12.002     Document Type: Article

References (41)

1. Sen G.C. Viruses and interferons. Annu Rev Microbiol 2001, 55:255-281.
2. Weber F., Kochs G., Haller O. Inverse interference. How viruses fight the interferon system. Viral Immunol 2004, 17:498-515.
3. Stetson D.B., Medzhitov R. Type I interferons in host defense. Immunity 2006, 25:373-381.
4. Buddaert W., Van Reeth K., Pensaert M. In vivo and in vitro interferon (IFN) studies with the porcine reproductive and respiratory syndrome virus (PRRSV). Adv Exp Med Biol 1998, 440:461-467.
5. Lee S.M., Schommer S.K., Kleiboeker S.B. Porcine reproductive and respiratory syndrome virus field isolates differ in in vitro interferon phenotypes. Vet Immunol Immunopathol 2004, 102:217-231.
6. Dufour V., Chevallier S., Cariolet R., Somasundaram S., Lefevre F., Jestin A., et al. Induction of porcine cytokine mRNA expression after DNA immunization and pseudorabies virus infection. J Interferon Cytokine Res 2000, 20:889-895.
7. Brukman A., Enquist L.W. Suppression of the interferon-mediated innate immune response by pseudorabies virus. J Virol 2006, 80:6345-6356.
8. Albina E., Carrat C., Charley B. Interferon-alpha response to swine arterivirus (PoAV), the porcine reproductive and respiratory syndrome virus. J Interferon Cytokine Res 1998, 18:485-490.
9. Ruggli N., Bird B.H., Liu L., Bauhofer O., Tratschin J.D., Hofmann M.A. N(pro) of classical swine fever virus is an antagonist of double-stranded RNA-mediated apoptosis and IFN-alpha/beta induction. Virology 2005, 340:265-276.
10. Rau H., Revets H., Balmelli C., McCullough K.C., Summerfield A. Immunological properties of recombinant classical swine fever virus NS3 protein in vitro and in vivo. Vet Res 2006, 37:155-168.
11. Bauhofer O., Summerfield A., Sakoda Y., Tratschin J.D., Hofmann M.A., Ruggli N. Classical swine fever virus Npro interacts with interferon regulatory factor 3 and induces its proteasomal degradation. J Virol 2007, 81:3087-3096.
12. Riffault S., Grosclaude J., Vayssier M., Laude H., Charley B. Reconstituted coronavirus TGEV virosomes lose the virus ability to induce porcine interferon-alpha production. Vet Res 1997, 28:77-86.
13. Vilar Gomez E., Gra Oramas B., Arus Soler E., Ruenes Domech C., Davila Gonzalez Y. Sequential combination therapy with prednisone, lamivudine and interferon alfa-2b for HBeAg-positive chronic hepatitis B. Gastroenterol Hepatol 2006, 29:534-541.
14. Zhao L.S. Problems and strategies during interferon therapy for hepatitis B. Zhonghua Gan Zang Bing Za Zhi 2006, 14:378-379.
15. Koyama R., Arase Y., Ikeda K., Suzuki F., Suzuki Y., Saitoh S., et al. Efficacy of interferon therapy in elderly patients with chronic hepatitis C. Intervirology 2006, 49:121-126.
16. Satoh J. Interferon-beta therapy in multiple sclerosis. Nippon Rinsho 2006, 64:1297-1309.
17. Yoshida J., Mizuno M., Wakabayashi T. Interferon-beta gene therapy for cancer: basic research to clinical application. Cancer Sci 2004, 95:858-865.
18. Miyake K., Tsuchida K., Sugino H., Imura S., Morine Y., Fujii M., et al. Combination therapy of human pancreatic cancer implanted in nude mice by oral fluoropyrimidine anticancer agent (S-1) with interferon-alpha. Cancer Chemother Pharmacol 2007, 59:113-126.
19. Mahmutovic S., Beslagic E. Significance of the interferon (IFN) in the therapy. Bosn J Basic Med Sci 2004, 4:42-44.
20. Kappos L., Hartung H.P. 10years of interferon beta-1b (Beta feron therapy. J Neurol 2005, 252(Suppl. 3):iii1-iii2.
21. Overend C., Mitchell R., He D., Rompato G., Grubman M.J., Garmendia A.E. Recombinant swine beta interferon protects swine alveolar macrophages and MARC-145 cells from infection with Porcine reproductive and respiratory syndrome virus. J Gen Virol 2007, 88:925-931.
22. Xia C., Dan W., Wen-Xue W., Jian-Qing W., Li W., Tian-Yao Y., et al. Cloning and expression of interferon-alpha/gamma from a domestic porcine breed and its effect on classical swine fever virus. Vet Immunol Immunopathol 2005, 104:81-89.
23. Pol J.M., Broekhuysen-Davies J.M., Wagenaar F., La Bonnardiere C. The influence of porcine recombinant interferon-alpha 1 on pseudorabies virus infection of porcine nasal mucosa in vitro. J Gen Virol 1991, 72(Pt 4):933-938.
24. Cao R.B., Zhou G.D., Zhou H.X., Bao J.J., Chen P.Y. Secreted expression of porcine interferon beta in Pichia pastoris and its inhibition effect on the replication of pseudorabies virus. Wei Sheng Wu Xue Bao 2006, 46:412-417.
25. Loignon M., Perret S., Kelly J., Boulais D., Cass B., Bisson L., et al. Stable high volumetric production of glycosylated human recombinant IFNalpha2b in HEK293 cells. BMC Biotechnol 2008, 8:65.
26. Meager A., Das R.G. Biological standardization of human interferon beta: establishment of a replacement world health organization international biological standard for human glycosylated interferon beta. J Immunol Methods 2005, 306:1-15.
27. Guo Y.J., Wu D., Chen R.W., Sun S.H. Cloning, high level expression and purification of porcine IFN gamma. Sheng Wu Gong Cheng Xue Bao 2001, 17:183-186.
28. Cao R.B., Xu X.Q., Zhou B., Chen D.S., Chen P.Y. Gene modification and high prokaryotic expression of porcine interferon alpha-1. Sheng Wu Gong Cheng Xue Bao 2004, 20:291-294.
29. Wan J.Q., Wu W.X., Xia C. Expression of porcine interferon-gamma gene in Pichia pastoris and its effect of inhibiting porcine reproductive and respiratory syndrome virus. Sheng Wu Gong Cheng Xue Bao 2002, 18:683-686.
30. Huang Z.Q., Hu H.Y., Chen X.L., Ren L.M., Lin A.X., Chen Y.F. Secreted expression of porcine interferon-gamma gene in Pichia pastoris. Sheng Wu Gong Cheng Xue Bao 2005, 21:731-736.
31. Huang H., Xie P., Yu R.S., Liu H.L., Zhang D.F., Cao X.R., et al. High level secretion expression of PoIFNalpha in Pichia pastoris. Yi Chuan 2005, 27:215-220.
32. Wang Y.B., Wang Z.Y., Chen H.Y., Cui B.A., Zhang H.Y., Wang R. Secretory expression of porcine interferon-gamma in baculovirus using HBM signal peptide and its inhibition activity on the replication of porcine reproductive and respiratory syndrome virus. Vet Immunol Immunopathol 2009, 132:314-317.
33. Qin L.T., Wang X.J., Hu S., Li Z.Z., Chen W.Y., Ge J.Y., et al. Expression of porcine gamma-interferon in recombinant baculovirus and determination of its antiviral activity. Sheng Wu Gong Cheng Xue Bao 2007, 23:386-391.
34. Meager A. Assays for antiviral activity. Methods Mol Biol 2004, 249:121-134.
35. Yeh T.J., McBride P.T., Overall J.C., Green J.A. Automated, quantitative cytopathic effect reduction assay for interferon. J Clin Microbiol 1982, 16:413-415.
36. Armstrong J.A. Cytopathic effect inhibition assay for interferon: microculture plate assay. Methods Enzymol 1981, 78:381-387.
37. Hu Y.X., Guo J.Y., Shen L., Chen Y., Zhang Z.C., Zhang Y.L. Get effective polyclonal antisera in one month. Cell Res 2002, 12:157-160.
38. Meager A. Biological assays for interferons. J Immunol Methods 2002, 261:21-36.
39. McCormick F., Trahey M., Innis M., Dieckmann B., Ringold G. Inducible expression of amplified human beta interferon genes in CHO cells. Mol Cell Biol 1984, 4:166-172.
40. Bekisz J., Schmeisser H., Hernandez J., Goldman N.D., Zoon K.C. Human interferons alpha, beta and omega. Growth Factors 2004, 22:243-251.
41. Rossmann C., Sharp N., Allen G., Gewert D. Expression and purification of recombinant, glycosylated human interferon alpha 2b in murine myeloma NSo cells. Protein Expr Purif 1996, 7:335-342.